iBio Inc. (NYSE AMERICAN: IBIO)
$2.11
-0.1700 ( -7.46% ) 164.8K
iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: Biopharmaceuticals and Bioprocessing activities, conducted within iBio, Inc. and CDMO segment, conducted within iBio CDMO.
Market Data
Open
$2.11
Previous close
$2.28
Volume
164.8K
Market cap
$18.54M
Day range
$2.07 - $2.47
52 week range
$1.02 - $15.99
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 22 | Jul 09, 2024 |
8-k | 8K-related | 13 | Jul 03, 2024 |
8-k | 8K-related | 17 | Jun 05, 2024 |
8-k | 8K-related | 82 | Jun 03, 2024 |
8-k | 8K-related | 18 | May 20, 2024 |
10-q | Quarterly Reports | 113 | May 13, 2024 |
4 | Insider transactions | 1 | May 13, 2024 |
4 | Insider transactions | 1 | May 13, 2024 |
8-k | 8K-related | 15 | May 13, 2024 |
4 | Insider transactions | 1 | Apr 26, 2024 |